Sponsored Content for Wayne Best

ASX listed PharmAust's wholly owned subsidiary Epichem has been named WA exporter of the year in recognition of the Perth-based company's ongoing excellence in the medicinal chemistry field. Epichem also received the Health and Biotechnology gong at the prestigious West Australian business event and PharmAust are predicting further rapid growth at the subsidiary, forecasting revenues of $4 million for FY18.

Epichem, a wholly owned subsidiary of ASX listed biotech hopeful Pharmaust, has reached the pinnacle of its 13 year existence with the opening of its new state of the art chemistry lab in Technology Park, Bentley. The new lab which is double the size of the old one previously operated on site at Murdoch University, cost $1.6m and boasts a serious brains trust of 13 PHD's amongst its 18 staff.